Literature DB >> 1445071

A comparison of the pathogenicity of two strains of hog cholera virus. 2. Virological studies.

S Kamolsiriprichaiporn1, C J Morrissy, H A Westbury.   

Abstract

Quantitative and qualitative differences were demonstrated in the amount of virus in a range of tissues from pigs infected with either the Weybridge or New South Wales (NSW) strains of hog cholera (HC) virus. The titre of the Weybridge strain in samples, as assessed by either virus titration in cell culture or by the density of specific fluorescing cells in tissue sections, was higher than that for the NSW strain. This correlated with the greater severity of the clinico-pathological syndrome induced by the Weybridge strain. The implications of the differences in the virus content of tissues in the diagnosis of HC is discussed as is the use of monoclonal antibodies to differentiate HC and bovine virus diarrhoea viruses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445071     DOI: 10.1111/j.1751-0813.1992.tb09871.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  3 in total

1.  Diagnosis of classical swine fever virus in a limited resource setting: the influence of pig breed on methodology and sample selection.

Authors:  S Khounsy; L J Gleeson; D Van Aken; H A Westbury; S D Blacksell
Journal:  Trop Anim Health Prod       Date:  2007-01       Impact factor: 1.559

2.  Development and evaluation of a rapid immunomagnetic bead assay for the detection of classical swine fever virus antigen.

Authors:  James V Conlan; Syseng Khounsy; Stuart D Blacksell; Christopher J Morrissy; Colin R Wilks; Laurence J Gleeson
Journal:  Trop Anim Health Prod       Date:  2008-11-29       Impact factor: 1.559

3.  Development of a reverse transcription multiplex real-time PCR for the detection and genotyping of classical swine fever virus.

Authors:  Yu-Liang Huang; Victor Fei Pang; Chu-Hsiang Pan; Tsu-Han Chen; Ming-Hwa Jong; Tien-Shine Huang; Chian-Ren Jeng
Journal:  J Virol Methods       Date:  2009-05-03       Impact factor: 2.014

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.